Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome
MILAN& MORRISTOWN, N.J. -- November 19, 2019 -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 19, 2019 Category: Pharmaceuticals Source Type: clinical trials
Telehealth Support to Increase Physical Activity in Rett Syndrome
Condition: Rett Syndrome Intervention: Behavioral: Telehealth-delivered participation strategies to increase physical activity Sponsors: Telethon Kids Institute; Rigshospitalet, Denmark; Ariel University; University of Haifa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials